Current Issue

REVIEW
Intracrine androgen metabolism in the meibomian gland: regulation, circadian control, and implications in dry eye disease

Takahito Miyake, Masao Doi

https://doi.org/10.1507/endocrj.EJ26-0148
 Featured Article  Vol 73 Issue 9 (September, 2026)
ORIGINAL
Differentiating TRAb-positive painless thyroiditis from Graves’ disease using biochemical and ultrasound findings

Yoshiki Furumura, Mitsuru Ito, Itaru Monno, Keitaro Miyamura, Shuji Fukata, Eijun Nishihara, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu

https://doi.org/10.1507/endocrj.EJ26-0047
Vol 73 Issue 9 (September, 2026)
ORIGINAL
Telomere length in patients with non-functional adrenal incidentalomas

Nilufer Ozdemir, Seda Sabah Ozcan, Ayse Ece Turkmen, Sedat Can Guney, Zeliha Hekimsoy, Mehmet Korkmaz

https://doi.org/10.1507/endocrj.EJ26-0033
Vol 73 Issue 9 (September, 2026)
ORIGINAL
Indicators for predicting continuous insulin infusion therapy-related hypokalemia: multicenter retrospective cohort study

Yuichiro Iwamoto, Tomohiko Kimura, Masato Kubo, Yui Okamoto, Ryo Inaba, Takashi Itoh, Toshitomo Sugisaki, Kazunori Dan, Hideyuki Iwamoto, Yoshiro Fushimi, Junpei Sanada, Hayato Isobe, Fuminori Tatsumi, Yukiko Kimura, Fumiko Kawasaki, Masashi Shimoda, Shuhei Nakanishi, Kohei Kaku, Hideaki Kaneto

https://doi.org/10.1507/endocrj.EJ26-0061
Vol 73 Issue 9 (September, 2026)
ORIGINAL
Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients

Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, Katsuhiko Masudo, Ai Matsui, Aya Saito

https://doi.org/10.1507/endocrj.EJ25-0629
Vol 73 Issue 9 (September, 2026)
ORIGINAL
Gender distribution in membership, leadership, and conference participation in the Japanese Society for Hypothalamic and Pituitary Tumors

Naoko Inoshita, Noriko Makita, Takayuki Matsuo, Masaaki Taniguchi, Hidetaka Suga, Hidenori Fukuoka, Hiroshi Nishioka

https://doi.org/10.1507/endocrj.EJ26-0154
Vol 73 Issue 9 (September, 2026)
ORIGINAL
The clinical significance of SIGLEC1 mRNA levels derived from peripheral leukocytes in autoimmune thyroid diseases and type 1 diabetes

Mami Gamo-Kawasaki, Shiori Kawai, Ayano Takei, Kazunori Fukuda, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Kohzo Takebayashi, Koshi Hashimoto

https://doi.org/10.1507/endocrj.EJ25-0639
Vol 73 Issue 9 (September, 2026)
CASE REPORT WITH REVIEW OF LITERATURE
Anti–pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literature

Hitomi Konishi, Yui Yamashita, Yuma Motomura, Shin Urai, Yumiko Sasai, Keiko Yamagami, Hironori Bando, Naotetsu Kanamoto

https://doi.org/10.1507/endocrj.EJ26-0108
Vol 73 Issue 9 (September, 2026)
CASE REPORT WITH REVIEW OF LITERATURE
Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature

Aysel Unver Ozkahraman, Merve Korkmaz Yilmaz, Huseyin Karatay, Sidar Bagbudar, Ebubekir Akpinar, Buruc Erkan, Mehmet Karagulle, Mesut Yilmaz, Mutlu Niyazoglu, Esra Hatipoglu

https://doi.org/10.1507/endocrj.EJ26-0079
Vol 73 Issue 9 (September, 2026)
LETTER TO THE EDITOR
Beyond tumor control: skeletal morbidity in giant prolactinoma

Taner Dandinoğlu

https://doi.org/10.1507/endocrj.EJ26-0353
Vol 73 Issue 9 (September, 2026)
LETTER TO THE EDITOR
Skeletal assessment in giant prolactinoma: a reply

Aysel Unver Ozkahraman, Esra Hatipoglu

https://doi.org/10.1507/endocrj.EJ26-0400
Vol 73 Issue 9 (September, 2026)

» Archives